Beam Therapeutics Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-210338
- Form type
- 10-Q
- CIK
- 0001745999
- Primary document
- https://www.sec.gov/Archives/edgar/data/1745999/000119312526210338/beam-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beam Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $31.7M | - | - |
| Operating Income | $-107.2M | - | - |
| Net Income | $-94.3M | - | - |
| Eps Basic | -0.91 | - | - |
| Eps Diluted | -0.91 | - | - |
| Cash And Equivalents | $288.3M | - | - |
| Total Assets | $1.5B | - | - |
| Total Liabilities | $316.4M | - | - |
| Shareholders Equity | $1.2B | - | - |
| Operating Cash Flow | $-128.5M | - | - |
| Capital Expenditures | $2.2M | - | - |